Previous Article | Next Article ![]()
Infection and Immunity, February 2002, p. 724-731, Vol. 70, No. 2
0019-9567/01/$04.00+0 DOI: 70.2.724-731.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Oral Biology and Pathology, School of Dentistry, University of Queensland, Brisbane, Queensland 4072,1 Discipline of ImmunologyMicrobiology, University of Newcastle, Newcastle, New South Wales 2300,,2 Department of Pathology, QEII Medical Centre, University of Western Australia, Nedlands, Western Australia 6907, Australia3
Received 23 July 2001/ Returned for modification 9 August 2001/ Accepted 8 November 2001
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The homozygous athymic nude mouse (nu/nu) is deficient in T lymphocyte number and function, analogous to DiGeorge syndrome in humans. In nu/nu mice, the thymus is almost totally absent due to the failure of the development of the thymic anlage, which arises from the ectoderm of the third pharyngeal pouch (36). This leads to many defects in the immune system, including depletion of lymphocytes from thymus-dependent areas of lymph nodes and spleen, a much reduced lymphocyte population composed mostly of B cells, relatively normal immunoglobulin M (IgM) response to thymus-independent antigens, very poor response to thymus-dependent antigens, and greatly increased susceptibility to infection (37).
T-cell-deficient nude mice have been widely used to evaluate the role of cell-mediated immune responses against Candida albicans infections in systemic (12, 19, 22, 30, 39), vaginal (10, 11), and mucosal (gastrointestinal) (13, 14) models of the disease. Work by our group (C. S. Farah, T. Gotjamanos, and R. B. Ashman, submitted for publication) has shown that an oral infection of mild to moderate severity and relatively short duration could be established in inbred mice of different genetic backgrounds. However, although oral C. albicans infection is known to elicit cell-mediated immune responses, there is no unequivocal evidence that T cells are essential for recovery from a primary infection with this yeast. A model of oral candidiasis in immunodeficient mice would allow immunological manipulation of the system and facilitate evaluation of the role of T cells in this infection.
As clinical observations support a role for T cells in oral candidiasis, T-cell-deficient mice provide an ideal model to study the role of T-cell-mediated immunity in oral candidiasis. The present paper reports the establishment of an oral C. albicans infection in T-cell-deficient mice and demonstrates the critical role of T cells in the clearance of the yeast from the oral tissues after primary infection.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Yeast. C. albicans isolate 3630, derived from a patient with cutaneous candidiasis, was obtained from the Mycology Reference Laboratory at the Royal North Shore Hospital, Sydney, Australia, and stored at -70°C in Sabouraud's broth with 15% (vol/vol) glycerol. For use, yeasts were grown in Sabouraud's broth for 48 h at room temperature with continuous agitation on a magnetic stirrer. Blastospores were washed in phosphate-buffered saline (PBS) and adjusted to the appropriate concentration for inoculation.
Oral infection. Mice were inoculated orally with 108 live C. albicans yeasts in 20 µl of PBS. The infection was monitored by swabbing the oral cavity with sterile cotton swabs moistened with sterile PBS and plating on Sabouraud's agar plates. Agar plates were incubated for 48 h at 37°C. All inoculation and sampling procedures were conducted under halothane anesthesia using an inhalation apparatus and a scavenging system. CFU were counted on Sabouraud's agar plates. The counts were assigned into five groups correlating with the level of recoverable yeasts from the oral cavity. This provided a semiquantitative measure of the level of floridity of the infection. The scoring system used was as follows: 0, no detectable yeasts; 1, 1 to 10 CFU/plate; 2, 11 to 100 CFU/plate; 3, 101 to 1,000 CFU/plate; and 4, 1,000+ CFU/plate.
Histopathology. Mice were sacrificed at various time points throughout the course of the experiment for histopathological examination of tissues. Thymus glands were fixed in 10% neutral buffered formalin (pH 7.0), sectioned, and stained with hematoxylin and eosin. Skulls were also fixed in buffered formalin and decalcified in a 5% formic acid-sodium formate mixture. Frontal sections of the skull were taken at approximately 3-mm intervals, with consecutive sections stained with hematoxylin and eosin and according to the periodic acid-Schiff technique. Sections were examined by light microscopy.
Footpad injection. Mice were injected subcutaneously in the footpad with 107 heat-killed C. albicans yeasts in 20 µl of PBS. This dose has previously been shown to produce optimal delayed-type hypersensitivity responses in mice (3). The contralateral footpad was injected with an equal volume of sterile PBS. Footpad thickness was measured using dial calipers (Mitutoyo). Each measurement was repeated three times on a minimum of five mice.
Preparation of splenocytes. Spleens were removed from donor mice, and spleen cells were obtained by pressing the spleens through a sterile metal sieve, followed by filtration through an 80-µm nylon mesh. The cells were resuspended in 6 ml of PBS, and lymphocytes were separated on a Ficoll gradient by underlaying the cell suspension with 4 ml of Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden). The gradient was centrifuged at 700 x g for 25 to 30 min at room temperature. The buffy coat interface was carefully removed, washed twice in PBS, and resuspended in 1 ml of PBS. Viable lymphocytes were counted in a hemacytometer after staining with trypan blue dye and adjusted to the appropriate concentration for injection into recipient mice.
Adoptive lymphocyte transfer in immunodeficient mice. At the height of oral infection (day 6 following oral challenge), 3 x 107 nonimmune lymphocytes from naive donor mice or 3 x 107 immune lymphocytes from previously immunized donor animals were injected intravenously into the respective immunodeficient recipient mice. Control animals received no cells and were used to monitor the normal course of infection. Donor mice were primed orally with 108 viable C. albicans yeasts and rested for 4 to 8 weeks before use.
Thymus transplant. Immunodeficient mice were inoculated orally with 108 viable yeasts. At the height of infection (day 6), thymuses from naive inbred mice, 6 to 8 weeks of age, were surgically removed and transplanted into nude animals subcutaneously under the right axilla. Control animals had sham operations performed. The surgical sites were closed with wound clips. At the termination of the experiment, the transplant site was examined visually and histologically to determine whether grafting of the thymus was successful.
Mouse CD4+ and CD8+ T-cell enrichment. T-cell enrichment was carried out using commercially available CD4+ and CD8+ mouse T-cell enrichment columns (R&D, Minneapolis, Minn.), according to the manufacturer's instructions. Spleen lymphocytes from naive inbred mice were obtained as described above and separated into CD4+ and CD8+ T cells on high-affinity negative-selection columns. Briefly, 1 ml of monoclonal antibody cocktail was mixed with 2 x 108 leukocytes in single-cell suspension and incubated at room temperature for 15 min. The cells were washed twice in 1x column buffer and resuspended in 2 ml of the same buffer. The antibody-treated cells were then applied to a subset column, incubated at room temperature for 10 min, and eluted with 10 ml of 1x column buffer. The isolated cells were centrifuged at 200 x g for 5 min and suspended in PBS at the appropriate concentration for injection.
Fluorescence-activated cell sorting (FACS) analysis (CellQuest version 3.1, FACSCalibur; Becton Dickinson, San Jose, Calif.) using fluorescein isothiocyanate (FITC)-conjugated rat anti-mouse CD4 (IgG2a) and R-phycoerythrin (PE)-conjugated rat anti-mouse CD8 (IgG2a) antibodies (Pharmingen, San Diego, Calif.) confirmed that the purity of cells isolated using these columns was 93.7% for CD4 and 89.8% for CD8.
CD4+ and CD8+ T-cell reconstitution. BALB/c nude mice were infected with 108 C. albicans yeasts. At the height of oral infection (day 6 following oral challenge), nude recipient mice were reconstituted with naíve CD4+ or CD8+ T cells as follows: either 2.5 x 106 CD4+ cells, 2.5 x 106 CD8+ cells, or a combination of 1.5 x 106 CD4+ and 1.5 x 106 CD8+ cells. A positive control group received 3 x 107 naíve lymphocytes, while a negative control group received no cells.
Cell surface antigen staining. Spleens or lymph nodes were isolated as described earlier and suspended in 0.1% PBS-NaN3. No Ficoll treatment was required for lymph node cells. A total of 106 cells were stained in 50 µl of 0.1% PBS-NaN3 for 30 min at 4°C in the dark, using an appropriate concentration of a fluorochrome-conjugated monoclonal antibody specific for a cell surface antigen or isotype control: 1 µl, 500 µg of FITC-rat anti-mouse CD4 (IgG2a); 1.5 µl, 200 µg of R-PE-rat anti-mouse CD8 (IgG2a); 1 µl, 500 µg of FITC-rat IgG2a isotype control immunoglobulin; and 1.5 µl, 200 µg of R-PE-rat IgG2a isotype control immunoglobulin (Pharmingen, San Diego, Calif.) per ml. The cells were washed twice in 0.1% PBS-NaN3 at 350 x g for 5 min and resuspended in 500 µl of 1% formalin. Cells were analyzed by FACS.
Cytokine ELISA.
Lymphocytes isolated from the submandibular and superficial cervical lymph nodes were cultured ex vivo for 3 days at 4 x 106 cells/ml in RPMI 1640 tissue culture medium without antigen stimulation. The supernatant was collected, filtered through a 0.8-µm filter, and stored at -20°C until analyzed. The culture supernatant was assayed for interleukin-4 (IL-4), IL-10, IL-12, and gamma interferon (IFN-
) by enzyme-linked immunosorbent assay (ELISA) using matched antibody pairs and recombinant cytokines as standards. Briefly, Immuno-Polysorb microtiter plates (Nunc, Rothskild, Denmark) were coated with capture rat monoclonal anti-IL-4 (IgG1), IL-10 (IgG1), IL-12 (IgG2a), or IFN-
(IgG1) antibody (Pharmingen) at 1 µg/ml in sodium bicarbonate buffer overnight at 4°C. The wells were washed and then blocked with 1% bovine serum albumin-PBS before the culture supernatants and the appropriate standard were added to each well. Biotinylated rat monoclonal anti-IL-4, -IL-10, -IL-12, or -IFN-
antibody (Pharmingen) at 2 µg/ml was added as the second antibody. Detection was carried out with streptavidin-peroxidase and tetramethylbenzidine. The results were expressed as net Candida-induced counts, from which the background was subtracted, and are shown as supernatant cytokine titer (picograms per milliliter) (mean ± standard error of the mean [SEM]) from lymphocytes pooled from a minimum of three mice per group per time point.
RT-PCR. For reverse transcription-PCR (RT-PCR), total RNA was extracted from oral tissues using Ultraspec RNA reagent (Biotecx Laboratories, Houston, Tex.) according to the manufacturer's instructions. cDNA was prepared by reverse transcription of 1 µg of each RNA, using an oligo(dT)15 primer and avian myeloblastosis virus reverse transcriptase (Promega, Madison, Wis.). Briefly, 4 µl of 25 mM MgCl2 solution, 2 µl of 10x PCR amplification buffer [670 mM Tris-HCl, 166 mM (NH4)2SO4, 4.5% Triton X-100, 2 mg of gelatin/ml] (BioTech International, Nedlands, Australia), 2 µl of a 10 mM deoxynucleoside triphosphate (dNTP) mix, 0.5 µl of RNasin, 0.75 µl (15 U) of avian myeloblastosis virus reverse transcriptase, 0.5 µg of oligo(dT)15 primer, and 1 µg of an mRNA sample were incubated in a 20-µl reaction mix at 42°C for 1 h, heated to 99°C for 5 min, then cooled on ice. cDNA was amplified by PCR in an amplification mix consisting of 2 µl of 25 mM MgCl2, 2.5 µl of 10x reaction buffer, 2 µl of 25 mM dNTP mix, 0.5 U of Taq DNA polymerase (Geneworks, Thebarton, Australia), the appropriate primer, and 1 µl of cDNA in a total volume of 25 µl. Negative controls (without cDNA) were included for all primers used in each run.
The mixture was amplified using a PTC-100 programmable thermal cycler (MJ Research Inc.). The amplification protocol was 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min for 35 to 40 cycles. Following amplification, 10 µl of product was analyzed by electrophoresis through 2.5% (wt/vol) agarose gels. The gels were stained with ethidium bromide and the bands were visualized with a UV transilluminator (GelDoc 2000; Bio-Rad, Regents Park, Australia) with appropriate software (MultiAnalyst version 1.1; Bio-Rad, Hercules, Calif.). Primer sequences for CD4 and CD8 were obtained from published data (34) and synthesized by Geneworks, Adelaide, South Australia. Data are representative of at least two separate experiments.
Statistics. Quantitative data were analyzed using the statistical features of GraphPad Prism version 2.01 (GraphPad Inc., San Diego, Calif.). Student's t test and one-way analysis of variance were used, with a P value of <0.05 considered significant unless otherwise stated.
| RESULTS |
|---|
|
|
|---|
|
|
|
Thymus transplantation. BALB/c nu/nu mice were transplanted with thymus glands from naive syngeneic mice 6 to 8 weeks of age. The thymus was transplanted into nude BALB/c mice 6 days after colonization with C. albicans. Mice that received the thymus transplant significantly reduced the infection by day 49, whereas control animals that only had sham surgery performed were still heavily colonized with the yeast (Fig. 4).
|
|
|
|
Histopathology of oral tissues in nu/nu mice following lymphocyte reconstitution. Following lymphocyte reconstitution in nude BALB/c mice, histopathological sections of the tongue showed markedly fewer Candida hyphae penetrating the superficial epithelium (Fig. 7A). The neutrophilic inflammatory infiltrate was less obvious, but intraepithelial polymorphonuclear lymphocytes (PMNLs) were still found, and the lamina propria was mildly lymphocytic (Fig. 7).
|
CD4 and CD8 gene expression in oral tissues. Since CD4+ and CD8+ T cells were capable of repopulating the draining lymph nodes and spleen in nude mice after lymphocyte reconstitution, it was desirable to demonstrate the presence of message for CD4 and CD8 in the oral tissues of these mice by RT-PCR. Agarose gels stained with ethidium bromide revealed no CD4 in oral tissues of nude mice infected with C. albicans without lymphocyte reconstitution (Fig. 8, lane 3). CD4 gene expression was detected in oral mucosa on days 4 and 8 after lymphocyte reconstitution (Fig. 8, lanes 5 and 7, respectively). CD4 was not detected in the tongue until day 21 following lymphocyte transfer (data not shown). CD8 was detected in infected controls (Fig. 8, lane 4) and reconstituted animals at all time points examined (Fig. 8, lanes 6 and 8).
|
produced on day 8 (442.2 ± 68.93 pg/ml), but this soon returned to baseline levels on days 14 (46.38 ± 4.37) and 21 (46.23 pg/ml). Only very small amounts of IL-10 (38.9 to 67.7 pg/ml) were produced, with no IL-4 detected in the cell supernatant at any time point. | DISCUSSION |
|---|
|
|
|---|
Previous work from our laboratory (21; Farah et al., submitted), along with other studies of experimental C. albicans infections of the mucosa (9, 17, 29, 33), has shown small numbers of yeasts and hyphae colonizing the palate and tongue of normal (euthymic) mice. Histopathological examination of the oral tissues from BALB/c and CBA/CaH nu/nu mice showed abundant hyphal elements penetrating the epithelium and microabscess formation, consisting mostly of polymorphonuclear phagocytes. The pseudomembrane-like appearance of C. albicans lining the oral cavity in nu/nu mice, especially CBA/CaH, is very similar to that in clinical thrush observed in patients with HIV and AIDS (28, 35). The increased fungal burden in the oral cavity of the CBA/CaH nu/nu strain might be related to the genetic susceptibility of the CBA/CaH strain to both oral (Farah et al., submitted) and systemic colonization (1-3, 5, 6).
The chronic oral infection established in nude mice provided a system in which immunological manipulation was exploited to confirm the importance of T cells in this infection. Nude mice that received a thymus transplant cleared the infection, as did mice that received syngeneic lymphocytes, confirming a role for T cells and thymus-dependent immunity in this model of oral infection. However, despite the difference in the severity of oral colonization, there was no difference in the rate of clearance between BALB/c nu/nu and CBA/CaH nu/nu mice after the transfer of naive lymphocytes into these mice. This is consistent with previous observations that tissue susceptibility to C. albicans is determined by innate and not by adaptive immune responses (7).
Surprisingly, lymphocytes transferred from orally primed animals markedly accelerated clearance in the CBA/CaH nude mice, but were no more effective than naive cells in promoting clearance of the yeast from the oral cavity of BALB/c nu/nu mice. This result is consistent with the increased antibody-mediated resistance against systemic challenge displayed by immune CBA/CaH compared to BALB/c mice (4, 8). The basis for this difference is unknown at present; however, BALB/c mice appear to have stronger innate immune defenses than CBA/CaH mice, so that the window for immunological enhancement of resistance is smaller in this strain. Since the host response is most probably mediated by cytokines produced by CD4+ T cells, it is possible that after activation, cells from naive mice can deliver levels of cytokines that are sufficient for optimal or near optimal recruitment and/or activation of the phagocytic effector cells. If this is the case, the increased number of Candida-specific cells present in the immune cell population may only be able to make a small difference to the magnitude or rapidity of the host response, particularly in the BALB/c strain.
There was a strong expression of delayed-type hypersensitivity in both BALB/c and CBA/CaH nude mice following the adoptive transfer of lymphocytes from primed but not naive mice. This is in sharp contrast to the patterns of clearance of oral infection after adoptive transfer of immune and naive cells discussed above, but is consistent with the reported lack of correlation between the magnitude of delayed-type hypersensitivity responses and clearance of systemic candidiasis (23). B-cell epitopes are known to differ between mouse strains (18), and it is likewise possible that subsets of CD4+ T cells also recognize different antigenic peptides of C. albicans presented in the context of major histocompatibility complex class II. Thus, delayed-type hypersensitivity cells may represent a memory subpopulation of CD4+ cells whose functions are irrelevant to the recruitment and/or activation of the effector cells responsible for clearance of the yeast from the oral cavity.
Naive CD4+ and CD8+ T-cell population subsets separated by a negative selection protocol were introduced intravenously into BALB/c nu/nu mice to examine the contribution of each to recovery from oral infection. The results show that CD4+ but not CD8+ T cells are capable of reducing the fungal burden in the oral tissues and eventually lead to the recovery of these mice from chronic oral candidiasis. Animals reconstituted with either CD4+ cells alone or a mixture of CD4+ and CD8+ T cells exhibit the same pattern of clearance as animals reconstituted with a pool of naive mixed lymphocytes. A significant delayed-type hypersensitivity response was also observed following reconstitution with CD4+ but not CD8+ T cells. It was clear that CD4+ T cells were able to localize in the infected oral mucosa and exert their activity there, as evidenced by the CD4 gene expression in the oral tissues following reconstitution.
Although animals that received only naive CD8+ T cells did not clear the infection, there was a slight decrease in colonization levels, which might have been due to the carryover of CD4+ T cells in the transferred cells. CD4+ cells constituted only a small number of the T-cell population in the lymph nodes of mice reconstituted with CD8+ T cells; and control mice that received no cells displayed comparable numbers of CD4+ T cells to that of the CD8+ group (data not shown). T-cell numbers in nude mice tend to increase with age (32), and this might account for the slight decline in yeast CFU recovered from these control mice late in the course of infection.
While
/ß T cells often predominate in oral mucosal epithelium, the percentages of
/
T cells are always considerably higher than in the periphery (24, 31, 38).
/
T cells show a sharp increase in number following either oral (17, 20) or gastrointestinal (25) infection with C. albicans, and in a recent study, mice made deficient in
/ß or
/
T cells (
- and
-chain T-cell receptor knockout mice, respectively) were shown to be more susceptible to orogastric candidiasis than immunocompetent controls (26).
The most abundant cytokine detected in the submandibular and superficial cervical lymph nodes of infected BALB/c nude mice following reconstitution with naive lymphocytes was IL-12. IL-12 is produced by phagocytic cells, B cells, and dendritic cells and acts on T lymphocytes and NK cells by inducing proliferation and production of cytokines, especially IFN-
. In vivo, IL-12 has been shown to be required for the induction of Th1 responses in systemic candidiasis (41), although its action may also be regulated by IFN-
(15). In a model of gastrointestinal candidiasis, both Th1 cytokines, such as IFN-
, and the Th2 cytokines IL-4 and IL-5 were produced by CD4+ cells from Peyer's patches and mesenteric lymph nodes at a time when the fungus was cleared from the stomach and intestine (16). In addition, treatment with soluble IL-4 receptor, which increased Th1 cells, was associated with enhanced yeast clearance. It was concluded that activation of Th1- but not Th2-like responses may be responsible for controlling gastrointestinal candidiasis and generating protective immunity. In contrast to these results, others have reported that neither IL-2 nor IFN-
played a role in protecting the oral cavity from candidal infection (14), even though CD4+ T lymphocytes were essential for host recovery.
From the data presented in the current study and those reported by others (14-16), there is little evidence that IL-2, IL-4, and IL-10 play a significant role in mucosal candidiasis. IL-12 and IFN-
were found in recovering reconstituted mice and may play some role in the clearance of C. albicans yeasts from the oral tissues of these animals. They are known to be involved in natural and acquired aspects of the immune response, and it is perhaps some aspect of this interaction that underlies the effector function of CD4+ T cells in the host response against oral candidiasis.
In conclusion, the present study demonstrates the essential role of CD4+ T cells in the clearance and recovery of immunodeficient mice from chronic oral candidiasis. Although these data are consistent with the body of evidence that implicates Th1 cytokines in recovery from candidiasis (40), the precise role of these cytokines in recovery from oral candidiasis remains to be determined.
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
We thank Slavica Pervan for preparation of the histological samples.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Ashman, R. B. 1998. A gene (Carg1) that regulates tissue resistance to Candida albicans maps to chromosome 14 of the mouse. Microb. Pathog. 25:333-335.[CrossRef][Medline] |
| 2. | Ashman, R. B. 1997. Genetic determination of susceptibility and resistance in the pathogenesis of Candida albicans infection. FEMS Immunol. Med. Microbiol. 19:183-189.[CrossRef][Medline] |
| 3. | Ashman, R. B. 1987. Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex. Immunogenetics 25:200-203.[CrossRef][Medline] |
| 4. | Ashman, R. B., E. M. Bolitho, and J. M. Papadimitriou. 1993. Patterns of resistance to Candida albicans in inbred mouse strains. Immunol. Cell. Biol. 71:221-225. |
| 5. | Ashman, R. B., A. Fulurija, and J. M. Papadimitriou. 1997. Evidence that two independent host genes influence the severity of tissue damage and susceptibility to acute pyelonephritis in murine systemic candidiasis. Microb. Pathog. 22:187-192.[CrossRef][Medline] |
| 6. | Ashman, R. B., A. Fulurija, and J. M. Papadimitriou. 1998. A second Candida albicans resistance gene (Carg2) regulates tissue damage, but not fungal clearance, in sublethal murine systemic infection. Microb. Pathog. 25:349-352.[CrossRef][Medline] |
| 7. | Ashman, R. B., and J. M. Papadimitriou. 1987. Murine candidiasis. Pathogenesis and host responses in genetically distinct inbred mice. Immunol. Cell. Biol. 65:163-171. |
| 8. | Ashman, R. B., and J. M. Papadimitriou. 1993. Strain dependence of antibody-mediated protection in murine systemic candidiasis. J. Infect. Dis. 168:511-513.[Medline] |
| 9. | Balish, E., M. J. Balish, C. A. Salkowski, K. W. Lee, and K. F. Bartizal. 1984. Colonization of congenitally athymic, gnotobiotic mice by Candida albicans. Appl. Environ. Microbiol. 47:647-652. |
| 10. | Black, C. A., F. M. Eyers, A. Russell, M. L. Dunkley, R. L. Clancy, and K. W. Beagley. 1999. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes. J. Reprod. Immunol. 45:1-18.[CrossRef][Medline] |
| 11. | Cantorna, M., D. Mook, and E. Balish. 1990. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect. Immun. 58:3813-3815. |
| 12. | Cantorna, M. T., and E. Balish. 1991. Acquired immunity to systemic candidiasis in immunodeficient mice. J. Infect. Dis. 164:936-943.[Medline] |
| 13. | Cantorna, M. T., and E. Balish. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58:1093-1100. |
| 14. | Cantorna, M. T., and E. Balish. 1991. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 59:2447-2455. |
| 15. | Cenci, E., A. Mencacci, G. Delsero, C. F. Dostiani, P. Mosci, A. Bacci, C. Montagnoli, M. Kopf, and L. Romani. 1998. IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection. J. Immunol. 161:3543-3550. |
| 16. | Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K. H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type-1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279-1288.[Medline] |
| 17. | Chakir, J., L. Cote, C. Coulombe, and N. Deslauriers. 1994. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol. Immunol. 9:88-94.[Medline] |
| 18. | Costantino, P. J., N. F. Gare, and J. R. Warmington. 1995. Humoral immune responses to systemic Candida albicans infection in inbred mouse strains. Immunol. Cell. Biol. 73:125-133.[Medline] |
| 19. | Cutler, J. E. 1976. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J. Reticuloendothel. Soc. 19:121-124.[Medline] |
| 20. | Elahi, S., G. Pang, R. Clancy, and R. B. Ashman. 2000. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect. Immun. 68:5771-5777. |
| 21. | Farah, C. S., S. Hong, S. Wanasaengsakul, S. Elahi, G. Pang, T. Gotjamanos, G. J. Seymour, R. L. Clancy, and R. B. Ashman. 2001. Irradiation-induced oral candidiasis in an experimental murine model. Oral Microbiol. Immunol. 16:358-363. |
| 22. | Fulurija, A., R. B. Ashman, and J. M. Papadimitriou. 1997. Increased tissue resistance in the nude mouse against Candida albicans without altering strain-dependent differences in susceptibility. J. Med. Vet. Mycol. 35:197-203.[Medline] |
| 23. | Hurtrel, B., P. H. Langrange, and J. C. Michel. 1981. Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice. Infect. Immun. 31:95-101. |
| 24. | Itohara, S., A. G. Farr, J. J. Lafaille, M. Bonneville, Y. Takagaki, W. Haas, and S. Tonegawa. 1990. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature 343:754-757.[CrossRef][Medline] |
| 25. | Jones-Carson, J., A. Vazquez-Torres, H. C. van der Heyde, T. Warner, R. D. Wagner, and E. Balish. 1995. / T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. Med. 1:552-557.[CrossRef][Medline] |
| 26. | Jones-Carson, J., A. Vazquez-Torres, T. Warner, and E. Balish. 2000. Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis. Infect. Immun. 68:2363-2365. |
| 27. | Kirkpatrick, C. H., R. R. Rich, and J. E. Bennett. 1971. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann. Intern. Med. 74:955-978. |
| 28. | Klein, R. S., C. A. Harris, C. B. Small, B. Moll, M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358.[Abstract] |
| 29. | Lacasse, M., C. Fortier, J. Chakir, L. Cote, and N. Deslauriers. 1993. Acquired resistance and persistence of Candida albicans following oral candidiasis in the mouse: a model of the carrier state in humans. Oral Microbiol. Immunol. 8:313-318.[Medline] |
| 30. | Lee, K. W., and E. Balish. 1981. Systemic candidosis in germfree, flora-defined and conventional nude and thymus-bearing mice. J. Reticuloendothel. Soc. 29:71-77.[Medline] |
| 31. | Lundqvist, C., S. Baranov, S. Teglund, S. Hammarstrom, and M. L. Hammarstrom. 1994. Cytokine profile and ultrastructure of intraepithelial gamma-delta T cells in chronically inflamed human gingiva suggest a cytotoxic effector factor. J. Immunol. 153:2302-2312.[Abstract] |
| 32. | MacDonald, H. R., R. K. Lees, B. Sordat, P. Zaech, J. L. Maryanski, and C. Bron. 1981. Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1, and Lyt-2 in congenitally athymic (nu/nu) mice: analysis by flow microfluorometry. J. Immunol. 126:865-870.[Abstract] |
| 33. | Martin, M. V. 1989. A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis. J. Med. Vet. Mycol. 27:63-70.[Medline] |
| 34. | Murray, L. J., R. Lee, and C. Martens. 1990. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20:163-170.[Medline] |
| 35. | Pankhurst, C., and M. Peakman. 1989. Reduced CD4+ T cells and severe oral candidiasis in absence of HIV infection. Lancet i:672. |
| 36. | Pantelouris, E. 1968. Absence of a thymus in a mouse mutant. Nature 217:370-371.[CrossRef][Medline] |
| 37. | Pantelouris, E. 1973. Athymic development in the mouse. Differentiation 1:437-450.[CrossRef][Medline] |
| 38. | Poussier, P., and M. Julius. 1994. Intestinal intraepithelial lymphocytes: the plot thickens. J. Exp. Med. 180:1185-1189. |
| 39. | Rogers, T. J., E. Balish, and D. D. Manning. 1976. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J. Reticuloendothel. Soc. 20:291-298.[Medline] |
| 40. | Romani, L. 1999. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2:363-367.[CrossRef][Medline] |
| 41. | Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, S. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909-915.[Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|